119 related articles for article (PubMed ID: 10819156)
1. [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]-trimethylammonium (McN-A-343)-related compounds. Effect of the butynyl chain inclusion into an aromatic unit on the potency for muscarinic receptors.
Tumiatti V; Angeli P; Andrisano V; Bolognesi ML; Cavalli A; Marucci G; Minarini A; Recanatini M; Rosini M; Melchiorre C
Bioorg Med Chem; 2000 Apr; 8(4):681-9. PubMed ID: 10819156
[TBL] [Abstract][Full Text] [Related]
2. Amide, urea, and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.
Nilsson BM; Vargas HM; Hacksell U
J Med Chem; 1992 Jul; 35(15):2787-98. PubMed ID: 1379640
[TBL] [Abstract][Full Text] [Related]
3. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
4. Dimethylsulfonium analogues of the muscarinic agent McN-A-343: [4-[[N-(3- or 4-halophenyl)carbamoyl]oxy]-2-butynyl] dimethylsulfonium perchlorates.
Mellin C; Vargas HM; Ringdahl B
J Med Chem; 1989 Jul; 32(7):1590-3. PubMed ID: 2472484
[TBL] [Abstract][Full Text] [Related]
5. Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle.
Unno T; Kwon SC; Okamoto H; Irie Y; Kato Y; Matsuyama H; Komori S
Br J Pharmacol; 2003 May; 139(2):337-50. PubMed ID: 12770939
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
[TBL] [Abstract][Full Text] [Related]
7. Analysis of miosis produced by McN-A-343 in anesthetized cats.
Koss MC; Wally JR
J Ocul Pharmacol Ther; 1995; 11(3):389-99. PubMed ID: 8590271
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
Davies RH; Scholes HE; Virdi S; Broadley KJ
J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
[TBL] [Abstract][Full Text] [Related]
9. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
Adachi S; Koike K; Takayanagi I
Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1997 Nov; 339(2-3):153-6. PubMed ID: 9473129
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of carbachol, McN-A-343 and AHR-602 on Ca(2+)-mobilization and Ca(2+)-influx pathways in taenia caeci.
Hishinuma S; Hongo I; Matsumoto Y; Narita F; Kurokawa M
Br J Pharmacol; 1997 Nov; 122(6):985-92. PubMed ID: 9401759
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
Eglen RM; Kenny BA; Michel AD; Whiting RL
Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-dependent relaxation induced by M1 muscarinic receptor activation in the rat small intestine.
Olgart C; Iversen HH
Br J Pharmacol; 1999 May; 127(1):309-13. PubMed ID: 10369487
[TBL] [Abstract][Full Text] [Related]
16. Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes.
Fuder H; Meincke M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):591-5. PubMed ID: 7689704
[TBL] [Abstract][Full Text] [Related]
17. New functionally selective muscarinic agonists.
Lambrecht G; Moser U; Grimm U; Pfaff O; Hermanni U; Hildebrandt C; Waelbroeck M; Christophe J; Mutschler E
Life Sci; 1993; 52(5-6):481-8. PubMed ID: 7680092
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of McN-A-343 on membrane current and contraction in guinea pig ventricular myocytes.
Shen JB; Jiang B; Pappano AJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):641-8. PubMed ID: 10411573
[TBL] [Abstract][Full Text] [Related]
19. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
Micheletti R; Schiavone A
J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]